Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Patterns of Tobacco Use in Low and Middle Income Countries by Tobacco Product and Sociodemographic Characteristics: Nationally Representative Survey Data From 82 Countries Publisher Pubmed



Theilmann M1 ; Lemp JM1 ; Winkler V1 ; Mannegoehler J2, 3 ; Marcus ME4 ; Probst C1, 5, 6 ; Lopezarboleda WA1 ; Ebert C7 ; Bommer C1, 4 ; Mathur M8 ; Andallbrereton G9 ; Bahendeka SK10 ; Bovet P11, 12 ; Farzadfar F13 Show All Authors
Authors
  1. Theilmann M1
  2. Lemp JM1
  3. Winkler V1
  4. Mannegoehler J2, 3
  5. Marcus ME4
  6. Probst C1, 5, 6
  7. Lopezarboleda WA1
  8. Ebert C7
  9. Bommer C1, 4
  10. Mathur M8
  11. Andallbrereton G9
  12. Bahendeka SK10
  13. Bovet P11, 12
  14. Farzadfar F13
  15. Ghasemi E13
  16. Mayige MT14
  17. Saeedi Moghaddam S15
  18. Mwangi KJ16, 17
  19. Naderimagham S13
  20. Sturua L18
  21. Atun R19, 20
  22. Davies JI21, 22
  23. Barnighausen T1, 19, 23
  24. Vollmer S4
  25. Geldsetzer P24, 25
Show Affiliations
Authors Affiliations
  1. 1. Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
  2. 2. Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
  3. 3. Medical Practice Evaluation Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
  4. 4. Department of Economics and Centre for Modern Indian Studies, University of Goettingen, Gottingen, Germany
  5. 5. Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
  6. 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada
  7. 7. RWI-Leibniz Institute for Economic Research, Essen, Germany
  8. 8. Quantitative Sciences Unit and Department of Pediatrics, Stanford University, Stanford, CA, United States
  9. 9. Port of Spain, Trinidad and Tobago
  10. 10. St Francis Hospital, Kampala, Uganda
  11. 11. Ministry of Health, Victoria, Seychelles
  12. 12. University Center for Primary Care and Public Health (Unisante), Lausanne, Switzerland
  13. 13. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  14. 14. National Institute for Medical Research, Dar es Salaam, Tanzania
  15. 15. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  16. 16. Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
  17. 17. Institute of Global Health, Faculty of Medicine, University of Geneva (UNIGE), Geneva, Switzerland
  18. 18. Non-Communicable Disease Department, National Center for Disease Control and Public Health, Tbilisi, Georgia
  19. 19. Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, United States
  20. 20. Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, MA, United States
  21. 21. MRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
  22. 22. Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
  23. 23. Africa Health Research Institute, Somkhele, South Africa
  24. 24. Division of Primary Care and Population Health, Stanford University, Stanford, CA, United States
  25. 25. Chan Zuckerberg Biohub, San Francisco, CA, United States

Source: The BMJ Published:2022


Abstract

Objectives: To determine the prevalence and frequency of using any tobacco product and each of a detailed set of tobacco products, how tobacco use and frequency of use vary across countries, world regions, and World Bank country income groups, and the socioeconomic and demographic gradients of tobacco use and frequency of use within countries. Design: Secondary analysis of nationally representative, cross-sectional, household survey data from 82 low and middle income countries collected between 1 January 2015 and 31 December 2020. Setting: Population based survey data. Participants: 1 231 068 individuals aged 15 years and older. Main outcome measures: Self-reported current smoking, current daily smoking, current smokeless tobacco use, current daily smokeless tobacco use, pack years, and current use and use frequencies of each tobacco product. Products were any type of cigarette, manufactured cigarette, hand rolled cigarette, water pipe, cigar, oral snuff, nasal snuff, chewing tobacco, and betel nut (with and without tobacco). Results: The smoking prevalence in the study sample was 16.5% (95% confidence interval 16.1% to 16.9%) and ranged from 1.1% (0.9% to 1.3%) in Ghana to 50.6% (45.2% to 56.1%) in Kiribati. The user prevalence of smokeless tobacco was 7.7% (7.5% to 8.0%) and prevalence was highest in Papua New Guinea (daily user prevalence of 65.4% (63.3% to 67.5%)). Although variation was wide between countries and by tobacco product, for many low and middle income countries, the highest prevalence and cigarette smoking frequency was reported in men, those with lower education, less household wealth, living in rural areas, and higher age. Conclusions: Both smoked and smokeless tobacco use and frequency of use vary widely across tobacco products in low and middle income countries. This study can inform the design and targeting of efforts to reduce tobacco use in low and middle income countries and serve as a benchmark for monitoring progress towards national and international goals. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Experts (# of related papers)